Abbott’s Bioresorbable Stent Shows Durable Results In ABSORB Trial
This article was originally published in The Gray Sheet
Executive Summary
Latest clinical results for Abbott’s Absorb Bioresorbable Vascular Scaffold show the disappearing stent actually increases the space inside the stented vessel segment over time. The company’s efforts to launch a pivotal randomized trial of the device are hindered by FDA, according to the lead investigator.